Jessy Delaye

9 papers receiving 394 citations

Jessy Delaye's Hit Papers

Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study 2018 · 240 citations
2400+2+5Years since publication50100150200

Peers

Jessy Delaye
Comparison fields: 5 of 42
  • Otorhinolaryngology 30
  • Pulmonary and Respiratory Medicine 191
  • Oncology 136
  • Cancer Research 53
  • Rheumatology 38
Replace Necati Alkış with:
Necati Alkış Türkiye
G.Q. Yang United States
Seiko Sawada‐Kitamura Japan
Rosa Rinaldi Italy
Kelly K. Curtis United States
Ondřej Ondič Czechia
Kanae Nosaka Japan
Camille Schiffler France
Dimitrios Krikelis Greece
Mitsutoshi Shiba Japan
Jessy Delaye relative to Necati Alkış Türkiye Necati Alkış's profile →
Citations per field
00.5×3.6×
Necati Alkış · 1×
Citations per year

Countries citing papers authored by Jessy Delaye

Since Specialization
Citations

This map shows the geographic impact of Jessy Delaye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessy Delaye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessy Delaye more than expected).

Fields of papers citing papers by Jessy Delaye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessy Delaye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessy Delaye. The network helps show where Jessy Delaye may publish in the future.

Co-authors

The 25 scholars most cited alongside Jessy Delaye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jessy Delaye Line = papers co-authored together Jessy Delaye links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1
Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study
Hit paper breakdown →
2018240
2 201948
3 201927
4 201926
5 201925
6 201622
7 20194
8 20184
9 20142

About Jessy Delaye

Jessy Delaye is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine, Oncology, Surgery and Neurology, having authored 9 papers that have together received 398 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (4 papers), Head and Neck Cancer Studies (4 papers), Cancer Diagnosis and Treatment (2 papers), Salivary Gland Tumors Diagnosis and Treatment (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Pharmaceutical Practices and Patient Outcomes (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Otorhinolaryngology (30 citations), Pulmonary and Respiratory Medicine (191 citations), Oncology (136 citations), Cancer Research (53 citations) and Rheumatology (38 citations). Jessy Delaye has collaborated with scholars based in France, Switzerland and Guadeloupe. Frequent co-authors include Sophie Piperno‐Neumann, Sylvie Chabaud, Jean‐Yves Blay, Nicolas Penel, Antoîne Italiano, Olivier Collard, Florence Duffaud, Emmanuelle Bompas, Christine Chevreau and Pascaline Boudou‐Rouquette. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology, Cancer Epidemiology, International Journal of Cancer and BMJ Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact